Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

BCX9930, an Oral Factor D Inhibitor, for the Potential Treatment of Alternative Pathway Mediated Diseases: Interim Results of a Phase 1 Study in Healthy Subjects

Matthew Davidson, PharmD, Amanda Mathis, PhD, Stuart Mair, MBChB, DRCOG, DCPSA, FFPM, Diane Gesty-Palmer, MD PhD, Melanie Cornpropst, PharmD, PhD, William P. Sheridan, MBBS, Xilin Chen, MDPhD, David Reynolds, BS MT, Cynthia Parker, BS, Yarlagadda S. Babu, PhD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-138475

Published: 2020

Journal Articles

Preclinical Characterization of BCX9930, a Potent Oral Complement Factor D Inhibitor, Targeting Alternative Pathway-Mediated Diseases Including Paroxysmal Nocturnal Hemoglobinuria (PNH)

Xilin Chen, MDPhD, Xiaogang Cheng, PhD, Qingde Liu, PhD, Saritha Muppa, MS, Cynthia Parker, BS, Fugang Zhu, PhD, Krishnan Raman, PhD, Pravin L Kotian, PhD, Yarlagadda S. Babu, PhD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-133921

Published: 2020